Netease Inc Ads (NTES) 172.91 $NTES Red Hat (RHT) Beats

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Netease Inc Ads (NTES) 172.91 $NTES

Red Hat (RHT) Beats on Q1 Earnings, to Acquire 3scale
Zacks Equity Research - Zacks Investment Research - Thu Jun 23, 8:00AM CDT
Red Hat Inc. (RHT) reported better-than-expected first quarter fiscal 2017 results but shares of the company were down 6.7% in aftermarket trading after the company's guidance for 2016 came below analysts' expectations.
NTES: 172.91 (+5.38), FB: 115.08 (+1.17), RHT: 78.39 (-1.36), CVLT: 45.57 (+0.64)

Netease.com Set to Possibly Pullback After Yesterday's Rally of 1.84%
Comtex SmarTrend(R) - Wed Jun 22, 12:21PM CDT
Netease.com (NASDAQ:NTES) traded in a range yesterday that spanned from a low of $165.02 to a high of $169.27. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $167.39 on volume of 549,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NTES: 172.91 (+5.38)

Twitter Unveils Engage App, Allows Posting of Longer Videos
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 9:39AM CDT
Twitter Inc. (TWTR) has launched a new iOS compatible app, Engage, for creators while allowing users to post longer videos of 140 seconds as against the 30 seconds time limit earlier.
NTES: 172.91 (+5.38), FB: 115.08 (+1.17), CVLT: 45.57 (+0.64), TWTR: 17.04 (+0.91)

Facebook Partners Media Firms Like BuzzFeed to Back "Live"
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 9:22AM CDT
Facebook Inc. (FB) is leaving no stone unturned to boost its Live video platform.
NTES: 172.91 (+5.38), FB: 115.08 (+1.17), GOOGL: 714.87 (+4.40), TWTR: 17.04 (+0.91)

Facebook Shareholders Approve Creation of Class C Shares
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 10:02AM CDT
As expected, Facebook Inc. (FB) founder and CEO Mark Zuckerberg will continue to hold his sway over the company as shareholders approved the creation of Class C shares at yesterday's shareholder meet.
NTES: 172.91 (+5.38), GLOB: 40.14 (+0.44), FB: 115.08 (+1.17), CVLT: 45.57 (+0.64)

4 Notable Tech Companies Cheaper than LinkedIn's $26 Billion Offer
Maher Syed - Zacks Investment Research - Wed Jun 15, 4:57PM CDT
These companies include HP Inc, NetEase, Nvidia, and Applied Materials. Will one of them be Microsoft's next acquisition target?
NTES: 172.91 (+5.38), LNKD: 190.45 (+0.13), AMAT: 24.52 (+0.55), MSFT: 51.91 (+0.92), HPQ: 12.95 (+0.34), NVDA: 48.49 (+1.26)

China Stocks in Focus as MSCI Considers Inclusion
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 9:54AM CDT
MSCI's decision to include mainland-listed shares will fulfill China's need for foreign investments and fuel demand for its companies.
WUBA: 46.63 (+1.38), BIDU: 163.92 (+1.70), NTES: 172.91 (+5.38), HSBC: 33.73 (+1.08), GOOGL: 714.87 (+4.40), CTRP: 40.65 (+0.55), JD: 21.46 (+0.26), BABA: 79.14 (+0.41)

Why You Shouldn't Bet Against NetEase (NTES) Stock
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 8:35AM CDT
NetEase (NTES) looks like an interesting choice for investors, as it is seeing solid estimate revisions and belongs to a great industry.
NTES: 172.91 (+5.38)

Surging Earnings Estimates Signal Good News for NetEase (NTES)
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 7:42AM CDT
NetEase (NTES) has a decent short-term momentum and it is seeing solid activity on the earnings estimate revision front too
NTES: 172.91 (+5.38)

Twitter's (TWTR) 32M Passwords Leaked and Now Up for Sale
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 9:23AM CDT
As per a LeakedSource report, there are some 32 million Twitter passwords that have been compromised with and available for sale on the dark web.
NTES: 172.91 (+5.38), LNKD: 190.45 (+0.13), FB: 115.08 (+1.17), TWTR: 17.04 (+0.91)

Netease.com Set to Possibly Rebound After Yesterday's Selloff of 1.91%
Comtex SmarTrend(R) - Thu Jun 09, 12:46PM CDT
Netease.com (NASDAQ:NTES) traded in a range yesterday that spanned from a low of $169.46 to a high of $174.62. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $172.49 on volume of 721,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
NTES: 172.91 (+5.38)

IBM Inks 10-Year Deal with Emirates Airline Worth $300M
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 9:21AM CDT
International Business Machines (IBM) has partnered with Middle East based airlines, Emirates.
NTES: 172.91 (+5.38), ELLI: 87.53 (+0.72), IBM: 155.35 (+2.43), FB: 115.08 (+1.17)

Zacks.com featured expert Kevin Matras highlights: Commercial Vehicle Group, Neogenomics and NetEase
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 8:30AM CDT
Zacks.com featured expert Kevin Matras highlights: Commercial Vehicle Group, Neogenomics and NetEase
NTES: 172.91 (+5.38), NEO: 8.30 (-0.10), CVGI: 5.55 (+0.35)

Explosive Returns with the Filtered Zacks Rank 5 Strategy
Kevin Matras - ZACKS - Tue Jun 07, 3:38PM CDT
Explosive Returns with the Filtered Zacks Rank 5 Strategy
NTES: 172.91 (+5.38), NEO: 8.30 (-0.10), CVGI: 5.55 (+0.35)

Oracle Falls on Lawsuit Alleging Accounting Irregularities
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 8:34AM CDT
Shares of Oracle Corporation (ORCL) fell 3.97% in yesterday's trading session, after the company was named in a lawsuit by a former employee.
NTES: 172.91 (+5.38), GOOGL: 714.87 (+4.40), HPE: 19.65 (+0.44), ORCL: 40.83 (+0.82)

Facebook Board Bent on Limiting Zuckerberg Majority Right?
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 8:22AM CDT
Facebook Inc (FB) board of directors is seemingly uncomfortable with founder and CEO Mark Zuckerberg calling the shots.
WUBA: 46.63 (+1.38), NTES: 172.91 (+5.38), FB: 115.08 (+1.17), DST: 117.17 (+2.09)

Netease.com Shares Up 19.7% Since SmarTrend's Buy Recommendation (NTES)
Comtex SmarTrend(R) - Fri Jun 03, 1:25AM CDT
SmarTrend identified an Uptrend for Netease.com (NASDAQ:NTES) on May 11th, 2016 at $145.01. In approximately 3 weeks, Netease.com has returned 19.72% as of today's recent price of $173.60.
NTES: 172.91 (+5.38)

The Zacks Analyst Blog Highlights: Rose Rock Midstream, Ryerson Holding, Tutor Perini and NetEase
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 8:30AM CDT
The Zacks Analyst Blog Highlights: Rose Rock Midstream, Ryerson Holding, Tutor Perini and NetEase
NTES: 172.91 (+5.38), RYI: 16.75 (+0.52), RRMS: 26.65 (+1.58), TPC: 24.16 (+0.63)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sirha Lyon® 2027: A New Chapter in Foodservice

Updated Category News Views 162

A Bold Step Forward There's a hearty aroma wafting from Lyon this January, and it's not just from the local gastronomy. Sirha Lyon® is queuing up for its 23rd edition, promising to turn the Foodservice and Hospitality sectors on their heads. Nearly 150,000 square meters of exhibition space packed to the rafters with over 4,300 exhibitors—this ain't your average trade...

Continue Reading
BCG Pinpoints Fatal Ignorance in Critical Mineral Risks

Updated Category News Views 0

Unseen Weakness in Industrial Giants Imagine staring right past a pothole while driving, then wondering why you keep popping your tires. That's where industrial companies find themselves today with critical minerals, according to a new wake-up call from Boston Consulting Group. The giant problem? Firms are blissfully unaware of the mosquitoes in their machines—tiny,...

Continue Reading
Fulcra Unveils DIY Web App Tool for AI Agent Users

Updated Category News Views 87

Fulcra Dynamics Pushes the Boundaries with New Tool There's always that moment when a company nudges the needle, and Fulcra Dynamics seems to have done just that with its latest release. They've unveiled an ingenious tool that promises a shake-up in how we build and use web applications with AI. It's the kind of move that makes you stop and wonder if we're witnessing the...

Continue Reading
Skechers Facing Class Action: Investors Urged to Act

Updated Category News Views 50

Skechers Under Fire: Fraud Allegations Surface Alright, if you've been around the stock block a while, you know these stories can often read like a suspense novel. Plot twist: Skechers U.S.A., Inc. (formerly NYSE: SKX) is now facing some serious accusations. There's a class action lawsuit claiming that some shady dealings went down during the company's $9.4 billion...

Continue Reading
Gildan's Troubling Legal Struggles: Investor Action Alert

Updated Category News Views 76

Gildan's Bumpy Ride: Legal Woes Unfold Well, folks, seems like Gildan Activewear Inc. (NYSE:GIL) is in for a bumpy ride, and not the kind that makes you feel alive, I tell ya. They've been slapped with a class action lawsuit, and the news ain't pretty. Accusations are flying hot about how they've been playing fast and loose with their financials. The Allegations: Channel...

Continue Reading
OncoHost's Research Links TKI Sensitivity to Biology

Updated Category News Views 163

Cracking the Code on TKI Sensitivity When it comes to medicine, sometimes the trickiest part is knowing which button to push—especially in the high-stakes world of metastatic renal cell carcinoma (mRCC). OncoHost just dropped a bombshell at the ESMO 2026 Congress about their new plasma proteomics model that lets us peer into what makes some patients click with Tyrosine...

Continue Reading
Bladex Declares Quarterly Dividend for Q3 2026

Updated Category News Views 61

Bladex's Steady Dividend: What's Under the Hood? Well, well, it looks like Bladex is doing the old dividend dance again. They've just announced a quarterly cash dividend of $0.6875 per share for the third quarter of 2026. It's scheduled for payout on November 24 to those who have their noses in the ledger come November 6—that's your record date, folks. Now, dividends...

Continue Reading
Post University Expands with New Tech and Health Degrees

Updated Category News Views 46

If you're looking to invest in an education with promising payoffs, you might look into what's cooking over at Post University. They've just dropped a bombshell of new programs sure to get some attention from tech heads and health nuts alike, and I can't help but think there's potential brewing here. New Academic Paths Emerge Post University isn't resting on its...

Continue Reading
Nucor's Q3 2026 Earnings: Strong Growth Amid Steel Surge

Updated Category News Views 89

Nucor's Solid Third Quarter Performance Nucor Corporation is flexing its muscles, reporting a robust third quarter for 2026. With net earnings hitting $1.32 billion and a diluted earnings per share of $5.80, the steel giant has shown it can more than hold its ground in a competitive market. Compare that to last quarter's $1.16 billion - we're seeing serious momentum....

Continue Reading
Surgery Partners Buyout: Fair Deal or Insider Jackpot?

Updated Category News Views 66

What's Going On With Surgery Partners? Alright, here's the scoop that shareholders can't ignore—Surgery Partners (NYSE:SGRY) could be heading under the scalpel itself with a proposed buyout by HealthSpan. For those holding onto SGRY stock, this might feel like watching the rerun of a medical drama where the ending ain't clear yet. Shareholders are set to get $23.50 a...

Continue Reading

Top 5 Most Recently Viewed Articles

Nanjing Medical University Marks Milestone with Celebrations

Updated Category News Views 59

Nanjing Medical University Celebrates a Landmark Anniversary Nanjing Medical University (NMU) recently observed its 90th anniversary with a series of memorable events at its Jiangning Campus. This celebration included a remarkable commemorative ceremony, an innovative development conference, a forum on medical education, and an exciting cultural gala that brought together...

Continue Reading
Revolutionary Gel Launch by Pelthos Therapeutics for Skin Care

Updated Category News Views 142

Pelthos Therapeutics Unveils groundbreaking treatment Pelthos Therapeutics Inc. (NYSE: PTHS) has recently made headlines by launching Zelsuvmi (berdazimer) topical gel 10.3%, an innovative treatment designed specifically for molluscum contagiosum, a highly contagious skin infection primarily affecting children but also adults. This product has been approved for home use...

Continue Reading
Investors Eye Future Gains as Sportradar Options Surge

Updated Category News Views 242

Understanding Sportradar Group AG's Current Options Activity Recently, there has been notable trading activity surrounding Sportradar Group AG (NASDAQ: SRAD), with options trades summing up to a substantial $476,040 detected by advanced algorithms. These figures hint at increasing investor engagement and interest in the company’s stock. What's particularly exciting is...

Continue Reading
GXO Logistics Sets Earnings Call for Fourth Quarter 2024 Insights

Updated Category News Views 91

GXO Logistics Plans Upcoming Earnings Call GXO Logistics, Inc. is preparing to hold its fourth quarter and full-year 2024 earnings conference call and webcast on a specified date in February 2025. This event is an important opportunity for investors and stakeholders to gain insight into the company's financial performance and strategic direction during a rapidly changing...

Continue Reading
Pimco Income Strategy Fund Achieves New Peak at $8.62

Updated Category News Views 143

Pimco Income Strategy Fund Reaches New Heights In an encouraging trading environment, the Pimco Income Strategy Closed Fund (PFL) stock soared, achieving an impressive 52-week high of $8.62. This milestone is a testament to the fund's remarkable recovery and the unwavering confidence of investors. Over the past year, PFL has showcased a commendable increase of 9.45%,...

Continue Reading